ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against tough lung and brain cancers
Disease control OngoingThis study tests an experimental pill called BDTX-1535 for people with advanced non-small cell lung cancer or a type of brain tumor called glioblastoma that have certain genetic changes. The goal is to find the best dose and see if the drug can shrink tumors or slow their growth.…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Can old medical records replace new drug trials? lung cancer study aims to find out
Knowledge-focused OngoingThis study looks at medical records from over 800 people with advanced lung cancer to see if they can recreate the results of two earlier clinical trials. The goal is not to test a new treatment, but to learn whether real-world data can be trusted for future research. Participant…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 08:13 UTC